By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) To Present At Rodman & Renshaw 17th Annual Global Investment Conference On September 9, 2015 9/1/2015 7:01:01 AM
Can-Fite BioPharma (CFBI) Reports Financial Results For Six Months Ended June 30, 2015 8/28/2015 6:53:41 AM
WHO Accepted "Piclidenoson" As Proposed New Generic Name For Can-Fite BioPharma (CFBI)'s Lead Drug Candidate CF101 7/29/2015 11:36:38 AM
Can-Fite BioPharma (CFBI) Joins Israeli Life Sciences Delegation to Japan On July 28 - 30, 2015 7/23/2015 11:54:44 AM
Can-Fite BioPharma (CFBI)'s CF602 Sexual Dysfunction Drug Backed By New Preclinical Data Progresses Towards An IND 6/29/2015 6:39:00 AM
Can-Fite BioPharma (CFBI) Subsidiary OphthaliX Inc. Signs Definitive Agreement To Acquire Improved Vision Systems 6/19/2015 6:14:03 AM
BIO2015: Can-Fite BioPharma (CFBI) To Exhibit At BIO International Convention In Philadelphia On June 15 - 18, 2015 6/15/2015 8:16:11 AM
Can-Fite BioPharma (CFBI) Granted Notice Of Allowance For Patent Covering Manufacturing Process Of CF101 In The U.S. 6/10/2015 6:45:45 AM
Can-Fite BioPharma (CFBI) Reports First Quarter 2015 Results 5/29/2015 6:56:11 AM
Can-Fite BioPharma (CFBI)'s Phase II Liver Cancer Trial Approved In Europe 5/11/2015 6:41:08 AM